Table 1 Characteristics of patients who underwent pretherapeutic FDG PET/CT
From: Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma
| Characteristic | Value |
|---|---|
| Number of patients | 38a |
| Age, years | |
| Median | 56 |
| Range | 24–82 |
| Gender, men/women | 25/13 |
| Follow-up duration, months | |
| Median | 32 |
| Range | 4–115 |
| Primary tumor size (cm) | |
| Median | 4 |
| range | 0.9–15.6 |
| pTNM stage | |
| I/II | 32 |
| III/IV | 6 |
| Nuclear grade (WHO grade) | |
| G1-G2 | 20 |
| G3-G4 | 14 |
| Histological subtype | |
| Type 1 | 7 |
| Type 2 | 27 |
| Treatments | |
| Radical nephrectomy | 19 |
| Partial nephrectomy | 18 |
| Targeted therapy | 1 |
| Disease progression | 12 |
| Histology | |
| Papillary RCC | 38 |